# Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer

> **NCT05647109** · — · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 244 (estimated)

## Conditions studied

- Endometrial Carcinoma Stage I
- Atypical Endometrial Hyperplasia

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05647109
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-01
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 244 (ESTIMATED)
- **Last updated:** 2025-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647109, "Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05647109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*